American Journal of Preventive Medicine最新文献

{"title":"Project School*Vape*Science: Combining Student-Led Research and E-Cigarette Prevention in Secondary Education.","authors":"Annika Burgard, Mareike Lüthgen, Maike Trümpelmann, Paul Axt, Henrike Faesser, Tobias Jagomast, Theresa Mohr, Daniel Drömann, Folke Brinkmann, Loana Penner, Klaas F Franzen","doi":"10.1016/j.amepre.2026.108413","DOIUrl":"https://doi.org/10.1016/j.amepre.2026.108413","url":null,"abstract":"<p><p>Electronic nicotine delivery systems (ENDS) are increasingly used by adolescents and represent a growing public health concern. In Germany, school-based nicotine prevention programs focusing on ENDS are rare. The prevention project School*Vape*Science was developed to integrate science education, health literacy, and participatory research in order to engage students in critically examining e-cigarette-related risks. This paper describes the implementation and initial acceptability of a participatory, science-based school program addressing ENDs use. The project comprised a six-week elective course and 90-minute educational sessions targeting students in grades 5-12 (11-19 years). The elective course introduced scientific methodology and facilitated student-led investigations of ENDS, including survey development and physiological data collection using medical devices, followed by discussion and presentation of results. Program evaluation was conducted using standardized digital questionnaires. In 2024, the program was implemented in three secondary schools in northern Germany. The six-week curriculum and associated 90-minute sessions were conducted within regular school structures. A total of 47 students participated in the six-week project groups, and 977 students attended the school-wide sessions. Evaluation data from 38 students of the project groups showed a mean enjoyment score of 7.08 (SD = 2.29) on a 10-point scale. Most respondents rated the course structure as logically coherent. The findings demonstrate that the School*Vape*Science program can be implemented within regular secondary school settings and is generally accepted by participating students. This participatory approach may serve as a scalable model for regional and longitudinal nicotine-prevention initiatives. Further research using controlled and longitudinal designs is required to assess potential effects on knowledge, risk perception, and ENDS-related behavior.</p>","PeriodicalId":50805,"journal":{"name":"American Journal of Preventive Medicine","volume":" ","pages":"108413"},"PeriodicalIF":4.5,"publicationDate":"2026-05-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147845663","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Prevalence and Reasons for Microdosing Cannabis, Psilocybin, LSD, and MDMA Among US Adults.","authors":"Kevin H Yang, Nora Satybaldiyeva, Wayne Kepner, Joseph Friedman, Siyuan Ping, Eric C Leas","doi":"10.1016/j.amepre.2026.108381","DOIUrl":"10.1016/j.amepre.2026.108381","url":null,"abstract":"<p><strong>Introduction: </strong>Microdosing involves consuming low doses of psychoactive substances, typically 1/5th to 1/20th of a recreational dose. Despite increasing public attention to cannabis and psychedelics amid evolving drug policies, epidemiological data on microdosing remain limited.</p><p><strong>Methods: </strong>A cross-sectional, web-based survey (Characterizing the Epidemiology of Cannabidiol Use Survey) of 1,525 US adults was conducted in October-November 2023 and analyzed in 2024-2025 using Ipsos KnowledgePanel. Participants reported lifetime microdosing of cannabis, psilocybin, lysergic acid diethylamide (LSD), and 3,4-Methylenedioxymethamphetamine (MDMA). Lifetime prevalence, frequency, and reasons for microdosing were assessed, along with associations with demographics, mental health, quality of life, and cannabis and psychedelic policy environments. Survey weights were applied to generate nationally representative estimates.</p><p><strong>Results: </strong>Cannabis was the most commonly microdosed substance (9.4%; 95% CI=8.0, 10.7; 24.1 million adults), followed by psilocybin (5.3%; 95% CI=4.3, 6.3; 13.7 million adults), LSD (4.8%; 95% CI=3.8, 5.9; 12.4 million adults), and MDMA (2.2%; 95% CI=1.5, 2.9; 5.7 million adults). Cannabis (41.2%; 95% CI=33.3, 49.5) was primarily microdosed for medical purposes (e.g., \"to manage pain\"), while psilocybin (66.6%; 95% CI=56.9, 75.1), LSD (59.2%; 95% CI=46.5, 70.8) and MDMA (86.0%; 95% CI=68.8, 94.5) were more commonly microdosed for recreational purposes (e.g., \"to get less high\"). Across all substances, lifetime microdose use was more prevalent among respondents reporting poorer mental health and among those residing in jurisdictions permitting recreational cannabis use and decriminalized psychedelic possession.</p><p><strong>Conclusions: </strong>Despite remaining illegal at the federal level, a considerable number of US adults reported microdosing cannabis, psilocybin, LSD, and MDMA in their lifetime. Microdosing was associated with poorer mental health and was more common among respondents who lived in environments with fewer restrictions on the use of cannabis and psychedelics. As policy reforms continue to expand, microdosing prevalence may increase, making ongoing surveillance essential for evidence-based public health responses.</p>","PeriodicalId":50805,"journal":{"name":"American Journal of Preventive Medicine","volume":" ","pages":"108381"},"PeriodicalIF":4.5,"publicationDate":"2026-05-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13155376/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147845672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Natural Transitions of Non–High-Density Lipoprotein Cholesterol Levels in Children Aged 9–11 Years","authors":"Yaxing Meng PhD ,&nbsp;Tetsuhiro Kidokoro PhD ,&nbsp;Natsuko Imai PhD ,&nbsp;Russell J. Thomson PhD ,&nbsp;Grant R. Tomkinson PhD ,&nbsp;Costan G. Magnussen PhD","doi":"10.1016/j.amepre.2025.108243","DOIUrl":"10.1016/j.amepre.2025.108243","url":null,"abstract":"<div><h3>Introduction</h3><div>U.S. guidelines recommend universal lipid screening in children aged between 9 and 11 years, with follow-up screening at ages 17–21 years. Non–high-density lipoprotein cholesterol is the preferred marker. However, the stability of non–high-density lipoprotein cholesterol within the screening window remains unclear. This study aimed to estimate the probabilities of non–high-density lipoprotein cholesterol transitioning between its classifications (acceptable, borderline high, and high) during the 9–11-year age period and the average duration that it remains stable within each classification.</div></div><div><h3>Methods</h3><div>This study included 496 Japanese children with non–high-density lipoprotein cholesterol measured between ages 9 and 11 years. Data were collected from 2015 to 2019, and analyses were conducted in 2024. A time-homogeneous continuous-time Markov model was used to estimate the probabilities of transitioning among non–high-density lipoprotein cholesterol classifications—acceptable (&lt;120 mg/dL), borderline high (120-144 mg/dL), and high (≥145 mg/dL)—and the average duration children remained in a given non–high-density lipoprotein cholesterol classification before transitioning.</div></div><div><h3>Results</h3><div>At the population level, all non–high-density lipoprotein cholesterol classifications identified at age 9 years were estimated to remain stable for more than 2 years. Children with acceptable non–high-density lipoprotein cholesterol had a mean duration of 10.6 years (95% CI=7.8, 14.5) before transitioning to another classification, with an estimated 0.90 probability of maintaining in the acceptable classification during the 9–11-year window.</div></div><div><h3>Conclusions</h3><div>Non–high-density lipoprotein cholesterol classifications identified at age 9 years remained stable for over 2 years, supporting the appropriateness of screening at any point within the 9–11-year window. These findings offer insights into optimal lipid-screening practices, thereby enhancing early cardiovascular disease prevention.</div></div>","PeriodicalId":50805,"journal":{"name":"American Journal of Preventive Medicine","volume":"70 5","pages":"Article 108243"},"PeriodicalIF":4.5,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145835165","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Digital and Social Media Platform Use and Awareness of \"The Real Cost\" E-Cigarette Youth Prevention Campaign Ads Among U.S. Youth.","authors":"Jamie Guillory, Merrybelle Guo, Anna MacMonegle, Elizabeth L Petrun Sayers, Leeann N Siegel, Allie Jaarsma, Mihaela Johnson, Annice Kim","doi":"10.1016/j.amepre.2026.108281","DOIUrl":"https://doi.org/10.1016/j.amepre.2026.108281","url":null,"abstract":"<p><strong>Introduction: </strong>For 10 years, \"The Real Cost\" has adapted to changing youth media use, with today's strategy focused on digital and social media. This study explores media platform use among \"The Real Cost\" Youth E-Cigarette Prevention Campaign audience, including audience segment differences and the relationship between platform use and campaign awareness.</p><p><strong>Methods: </strong>Data were from 2 waves of the campaign evaluation: baseline (n=5,257), collected in 2023, and first follow-up (n=4,067), collected in 2024 (data were analyzed in 2024 and 2025). The sample includes U.S. youth aged 11-17 years at baseline. Descriptive analyses explored the patterns of individual digital and social media platform use (e.g., YouTube, Instagram). Weighted bivariate analyses and chi-squares explored subgroup differences in platform use. Multivariable regressions were run for media use indices (any use, heavy use, frequency of use) with (1) demographic and tobacco use characteristics as independent variables and (2) campaign E-cigarette ad awareness (any awareness, frequency of awareness) as dependent variables.</p><p><strong>Results: </strong>Almost all youth reported multiple platform use. The most commonly used platforms were also used most heavily. Older youth, youth reporting psychological distress, and youth who ever or currently used E-cigarettes had higher use (all media use indices) than referent groups. All indices were positively associated with any campaign ad awareness.</p><p><strong>Conclusions: </strong>Certain audience segments, including older youth and youth reporting E-cigarette use, consumed more media, suggesting ample opportunities to reach these segments efficiently. Airing the campaign on various media platforms reaches teens on the digital and social platforms where they spend time.</p>","PeriodicalId":50805,"journal":{"name":"American Journal of Preventive Medicine","volume":" ","pages":"108281"},"PeriodicalIF":4.5,"publicationDate":"2026-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147787642","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Attention-deficit/hyperactivity disorder in childhood and criminal justice involvement in young adulthood: A prospective U.S. cohort study.","authors":"Myriam Casseus, Hope Corman, Kelly Noonan, Nancy E Reichman","doi":"10.1016/j.amepre.2026.108397","DOIUrl":"https://doi.org/10.1016/j.amepre.2026.108397","url":null,"abstract":"<p><strong>Introduction: </strong>Individuals with attention-deficit/hyperactivity disorder (ADHD) are overrepresented in the criminal justice system, and children and youth with ADHD are at increased risk of engaging in rule-breaking and delinquent behaviors. This study investigated associations between ADHD in childhood and criminal justice involvement in adolescence and young adulthood.</p><p><strong>Methods: </strong>Data were from the Future of Families and Child Wellbeing Study, a longitudinal U.S. population-based birth cohort study (n=2,733) that randomly sampled births in large U.S. cities in 1998-2000. ADHD diagnosis and use of prescribed ADHD medication were reported at age 15, while criminal justice involvement was reported at age 22. Logistic regression models estimated associations between ADHD and criminal justice involvement. Data were analyzed in 2025.</p><p><strong>Results: </strong>Childhood ADHD was significantly associated with higher odds of juvenile justice system involvement (AOR [adjusted odds ratio] =1.77, p<.01), being arrested (before and after age 18), charged with a crime after age 18, and incarcerated after age 18. However, childhood ADHD was not significantly associated with being stopped by police at age ≥15. AORs remained statistically significant after adjusting for both sociodemographic characteristics and medication use.</p><p><strong>Conclusions: </strong>Childhood ADHD is significantly associated with criminal justice involvement in adolescence and young adulthood. Findings suggest an important opportunity for early intervention to prevent a trajectory toward criminal behavior.</p>","PeriodicalId":50805,"journal":{"name":"American Journal of Preventive Medicine","volume":" ","pages":"108397"},"PeriodicalIF":4.5,"publicationDate":"2026-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147823181","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Cannabis in Transition: Medicalization, Legalization, and Implications for Health.","authors":"Silvia S Martins, Johannes Thrul","doi":"10.1016/j.amepre.2026.108396","DOIUrl":"https://doi.org/10.1016/j.amepre.2026.108396","url":null,"abstract":"","PeriodicalId":50805,"journal":{"name":"American Journal of Preventive Medicine","volume":" ","pages":"108396"},"PeriodicalIF":4.5,"publicationDate":"2026-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147788268","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Mapping Healthcare Financial Burden: County-Level Out-of-Pocket Spending in the U.S.","authors":"Pedro Rafael Vieira de Oliveira Salerno, Zhuo Chen, Salil Deo, Khurram Nasir, Sadeer Al-Kindi","doi":"10.1016/j.amepre.2026.108390","DOIUrl":"https://doi.org/10.1016/j.amepre.2026.108390","url":null,"abstract":"<p><strong>Background: </strong>Out-of-pocket (OOP) healthcare costs can be associated with substantial financial burden, particularly when considered relative to local income. While prior work has characterized geographic variation in healthcare spending, less is known about how OOP spending relates to local economic capacity.</p><p><strong>Methods: </strong>This is a longitudinal ecological county-level analysis of OOP healthcare spending relative to per capita income (PCI) across the U.S. from 2010-2019. All ages county-level per capita mean OOP spending estimates were obtained from the IHME, and county-level per capita personal income was obtained from the BEA. The ratio of OOP spending to PCI was calculated as a measure of population-level healthcare financial burden. National trends were summarized using population-weighted medians and interquartile ranges (IQR). Change over time was quantified via estimated annual percentage changes (EAPCs).</p><p><strong>Results: </strong>Among 3,085 U.S. counties with available data, the national median OOP-to-income ratio declined from 2.09% (interquartile range [IQR], 1.82-2.49) in 2010 to 1.57% (IQR, 1.37-1.84) in 2019, corresponding to a EAPC of -2.61% (95% CI, -3.02 to -2.23). While most counties experienced decreasing burden, clusters of increasing OOP burden were observed, including in parts of New York, West Virginia, and the Upper Midwest.</p><p><strong>Conclusions: </strong>Although population-level OOP healthcare burden declined nationally over the past decade, this improvement was uneven across counties. Integrating OOP spending with local income reveals substate hotspots of financial burden that may be obscured by broader geographic averages, providing a scalable framework to inform geographically targeted health system planning and policy evaluation.</p>","PeriodicalId":50805,"journal":{"name":"American Journal of Preventive Medicine","volume":" ","pages":"108390"},"PeriodicalIF":4.5,"publicationDate":"2026-04-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147787595","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparability of Mortality Rates from Health Surveys Linked to National Death Index, 2015 vs 2019: Revised Methods Alter Results for Minoritized and Immigrant Groups.","authors":"Jenny S Guadamuz, Adrian Bacong, Stacy Chen, Gregory S Calip, Arturo Vargas Bustamante","doi":"10.1016/j.amepre.2026.108388","DOIUrl":"https://doi.org/10.1016/j.amepre.2026.108388","url":null,"abstract":"<p><strong>Introduction: </strong>The National Health Interview Survey (NHIS) Linked Mortality File (LMF) is vital for evaluating US mortality disparities. Its most recent iteration, LMF 2019, adopted a linkage approach that differed from earlier algorithms. While overall mortality estimates remain similar between LMF 2015 and 2019, the impact of newer methods on marginalized racial/ethnic and immigrant populations, remains unclear. To determine whether these changes disproportionately affect mortality estimates for marginalized populations, mortality estimates from LMF 2015 and 2019 were compared across racial/ethnic and immigrant groups.</p><p><strong>Methods: </strong>Cohort study using NHIS (1998-2014, 1072404 participants, analysis in 2025) with follow-up through 2015 (based on deaths captured in LMF 2015 and 2019). Cox proportional hazards regressions were used to assess the associations. All mortality rates (per 10,000 person-years) and hazard ratios (HRs) were survey-weighted and adjusted for age and sex.</p><p><strong>Results: </strong>LMF 2015 and 2019 resulted in similar overall mortality rates (114 vs. 110 per 10,000 person-years,1%Δ), but substantial declines among Latinx (124 vs. 85, -31%Δ), Asian (109 vs. 73, -33%Δ), and noncitizen (123 vs. 75, -39%Δ) populations. Consequently, observed mortality patterns often reversed. For example, LMF 2015 showed that Latinx participants were more likely to die than their White counterparts (HR=1.13 [CI:1.10-1.15]), but LMF 2019 suggested the opposite (HR=0.77 [CI:0.75-0.79]). The two LMF versions diverged most significantly for the population under age 50, where both the magnitude and direction of mortality disparities by race/ethnicity and citizenship shifted substantially.</p><p><strong>Conclusions: </strong>Among Latinx, Asian, and immigrant populations, mortality estimates from LMF 2015 and 2019 differ substantially, bringing into question the validity of previous/ongoing research evaluating mortality inequities with LMF. Government agencies conducting surveys and complex data linkages should ensure that methodological changes result in reliable information for marginalized populations, especially those less likely to report the identifiers necessary for data linkage.</p>","PeriodicalId":50805,"journal":{"name":"American Journal of Preventive Medicine","volume":" ","pages":"108388"},"PeriodicalIF":4.5,"publicationDate":"2026-04-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147788259","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Racial differences in the association of physical disability and healthcare access with firearm violence at the neighborhood level in Chicago, 2011-2023.","authors":"Bennett Allen, Cale Basaraba, Madison Offstein, Spruha Joshi, Jacquelyn Jacobs","doi":"10.1016/j.amepre.2026.108384","DOIUrl":"https://doi.org/10.1016/j.amepre.2026.108384","url":null,"abstract":"<p><strong>Introduction: </strong>Firearm violence remains a public health crisis in the United States, disproportionately affecting racially marginalized and historically disinvested neighborhoods. The relationship between neighborhood-level disability prevalence and healthcare access with firearm violence risk remains poorly understood.</p><p><strong>Methods: </strong>This ecological, spatiotemporal analysis of 77 community areas in Chicago from 2011 to 2023 used Bayesian negative binomial models to estimate associations between community-level disability prevalence and healthcare underservice-defined as proportion of land designated as a Medically Underserved Area (MUA)-with annual rates of nonfatal firearm victimizations and firearm homicides. Stratified models by neighborhood racial/ethnic plurality were also explored. Analyses were conducted from April 2025 to March 2026.</p><p><strong>Results: </strong>A 5-percentage point increase in disability prevalence was associated with a 10% higher rate of firearm victimization (95% credible interval [CrI], 2%-18%) and an 19% higher rate of firearm homicide (95% CrI, 8%-31%). A 5-percentage point increase in MUA coverage was associated with a 10% increase in firearm victimization (95% CrI, 6%-15%) and 9% increase in firearm homicide (95% CrI, 5%-13%). In stratified models, disability was most strongly associated with firearm violence in plurality non-Hispanic Black neighborhoods. Associations between MUA coverage and firearm violence were largest in plurality non-Hispanic white and Hispanic neighborhoods.</p><p><strong>Conclusions: </strong>Neighborhood-level disability and healthcare underservice are significantly associated with firearm violence in Chicago, with differences by racial/ethnic composition. Findings underscore the need to integrate disability and healthcare access into public health violence prevention frameworks.</p>","PeriodicalId":50805,"journal":{"name":"American Journal of Preventive Medicine","volume":" ","pages":"108384"},"PeriodicalIF":4.5,"publicationDate":"2026-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147787797","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Reported toxicology testing in U.S. violent deaths and suicides, 2023.","authors":"Marissa Zwald, Daniel A Bowen, Kristin Holland, Katherine Fowler, Carter Betz, Steven Sumner, M Allison Arwady","doi":"10.1016/j.amepre.2026.108395","DOIUrl":"https://doi.org/10.1016/j.amepre.2026.108395","url":null,"abstract":"","PeriodicalId":50805,"journal":{"name":"American Journal of Preventive Medicine","volume":" ","pages":"108395"},"PeriodicalIF":4.5,"publicationDate":"2026-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147787896","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}